Croda International (LON:CRDA) Given New GBX 3,000 Price Target at Deutsche Bank Aktiengesellschaft

Croda International (LON:CRDA) had its price objective decreased by Deutsche Bank Aktiengesellschaft from GBX 3,100 to GBX 3,000 in a research report report published on Tuesday, MarketBeat reports. Deutsche Bank Aktiengesellschaft currently has a hold rating on the stock.

Croda International Trading Up 1.6%

Shares of Croda International stock opened at GBX 2,739 on Tuesday. The company has a debt-to-equity ratio of 34.76, a current ratio of 1.99 and a quick ratio of 2.25. Croda International has a 1 year low of GBX 2,426.77 and a 1 year high of GBX 3,312. The firm has a market cap of £3.82 billion, a PE ratio of 61.69, a PEG ratio of 1.40 and a beta of 0.96. The company has a 50 day simple moving average of GBX 2,841.81 and a two-hundred day simple moving average of GBX 2,779.23.

Croda International (LON:CRDA) last issued its quarterly earnings results on Tuesday, February 24th. The company reported GBX 146.20 EPS for the quarter. Croda International had a net margin of 3.65% and a return on equity of 2.82%. Analysts expect that Croda International will post 181.8307268 earnings per share for the current fiscal year.

Insider Buying and Selling at Croda International

In other news, insider Tom Brophy sold 1,020 shares of the company’s stock in a transaction dated Tuesday, March 17th. The stock was sold at an average price of GBX 2,652, for a total value of £27,050.40. Also, insider Danuta Gray acquired 750 shares of the business’s stock in a transaction dated Friday, March 6th. The stock was purchased at an average price of GBX 2,788 per share, with a total value of £20,910. Insiders have bought 766 shares of company stock worth $2,136,858 over the last 90 days. Corporate insiders own 0.83% of the company’s stock.

About Croda International

Founded in 1925 with the aim of turning bio-based raw materials into innovative ingredients, Croda International is a speciality chemicals company focused on consumer care and life sciences markets. The company is focused on creating, making and selling innovative ingredients that deliver real benefits to a diverse range of customers and employs more than 6,000 people around the world. Sustainability is a core part of the Groups strategy with a commitment to be Climate, Land and People positive by 2030.